Compounds > carvedilol

carvedilol and ng-nitroarginine methyl ester

carvedilol has been researched along with ng-nitroarginine methyl ester in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ko, YS; Lee, PY; Su, CH; Tian, TY; Tsai, CH; Yeh, HI1
Afonso, RA; Carmo, MM; Macedo, MP; Patarrao, RS1
Bernabeu, E; Bertera, F; Bramuglia, GF; Buontempo, F; Chiappetta, D; Di Verniero, CA; Höcht, C; Mayer, MA; Taira, CA1
Chen, J; Huang, C; Huang, Q; Xu, L; Zhang, B1
Berg, G; Bertera, FM; Carranza, A; Chiappetta, DA; Del Mauro, JS; Donato, M; Fernandez Machulsky, N; Gelpi, RJ; González, GE; Gorzalczany, SB; Höcht, C; Morales, C; Morettón, MA; Prince, PD; Taira, CA1

Other Studies

5 other study(ies) available for carvedilol and ng-nitroarginine methyl ester

ArticleYear
Reduced expression of endothelial connexins 43 and 37 in hypertensive rats is rectified after 7-day carvedilol treatment.
    American journal of hypertension, 2006, Volume: 19, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Atenolol; Biomarkers; Blood Pressure; Blotting, Northern; Blotting, Western; Carbazoles; Carvedilol; Cells, Cultured; Connexin 43; Connexins; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Follow-Up Studies; Gap Junction alpha-4 Protein; Humans; Hypertension; Immunohistochemistry; In Vitro Techniques; Microscopy, Confocal; NG-Nitroarginine Methyl Ester; Propanolamines; Rats; Rats, Sprague-Dawley; Time Factors; Treatment Outcome; Umbilical Veins

2006
Carvedilol action is dependent on endogenous production of nitric oxide.
    American journal of hypertension, 2006, Volume: 19, Issue:4

    Topics: Adrenergic Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Hemodynamics; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Propanolamines; Rats; Rats, Wistar

2006
Enantioselective pharmacokinetic-pharmacodynamic modelling of carvedilol in a N-nitro-l-arginine methyl ester rat model of secondary hypertension.
    The Journal of pharmacy and pharmacology, 2010, Volume: 62, Issue:7

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Inactivation, Metabolic; Male; Models, Biological; NG-Nitroarginine Methyl Ester; Propanolamines; Random Allocation; Rats; Rats, Wistar; Stereoisomerism; Sympatholytics

2010
The effects of carvedilol on cardiac structural remodeling: the role of endogenous nitric oxide in the activity of carvedilol.
    Molecular medicine reports, 2013, Volume: 7, Issue:4

    Topics: Animals; Blood Pressure; Carbazoles; Carvedilol; Heart; Hypertension, Renovascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Propanolamines; Rats; Renal Artery; Ventricular Remodeling

2013
Effects of carvedilol or amlodipine on target organ damage in L-NAME hypertensive rats: their relationship with blood pressure variability.
    Journal of the American Society of Hypertension : JASH, 2017, Volume: 11, Issue:4

    Topics: Amlodipine; Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Blood Pressure Determination; Carbazoles; Carvedilol; Collagen; Disease Models, Animal; Fibrosis; Heart Ventricles; Humans; Hypertension; Interleukin-6; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; NG-Nitroarginine Methyl Ester; Propanolamines; Rats; Rats, Wistar; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2017